A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

December 17, 2021

Primary Completion Date

January 20, 2024

Study Completion Date

January 31, 2028

Conditions
Acromegaly
Interventions
DRUG

Paltusotine

Paltusotine, tablets, once daily by mouth

DRUG

Placebo

Placebo, tablets, once daily by mouth

Trial Locations (57)

1062

Crinetics Study Site, Budapest

1083

Crinetics Study Site, Budapest

1425

Crinetics Study Site, CABA

1431

Crinetics Study Site, Sofia

7624

Crinetics Study Site, Pécs

10117

Crinetics Study Site, Berlin

10676

Crinetics Study Site, Athens

11527

Crinetics Study Site (b), Athens

13395

Crinetics Study Site, Marseille

15213

Crinetics Study Site, Pittsburgh

19104

Crinetics Study Site, Philadelphia

31400

Crinetics Study Site, Toulouse

33604

Crinetics Study Site, Pessac

43210

Crinetics Study Site, Columbus

52074

Crinetics Study Site, Aachen

54642

Crinetics Study Site, Thessaloniki

80045

Crinetics Study Site, Aurora

80336

Crinetics Study Site, München

81667

Crinetics Study Site, München

97080

Crinetics Study Site, Würzburg

97239

Crinetics Study Site, Portland

100730

Crinetics Study Site (b), Beijing

110029

Crinetics Study Site, Delhi

160012

Crinetics Study Site, Chandigarh

250063

Crinetics Study Site, Jinan

310009

Crinetics Study Site, Hangzhou

400012

Crinetics Study Site, Mumbai

410003

Crinetics Study Site, Changsha

430030

Crinetics Study Site, Wuhan

450000

Crinetics Study Site, Zhengzhou

510080

Crinetics Study Site, Guangzhou

560054

Crinetics Study Site, Bangalore

590010

Crinetics Study Site, Belagavi

610041

Crinetics Study Site, Chengdu

682041

Crinetics Study Site, Kochi

710032

Crinetics Study Site, Xi’an

1228000

Crinetics Study Site, São Paulo

4941492

Crinetics Study Site, Petah Tikva

30130100

Crinetics Study Site, Belo Horizonte

02114

Crinetics Study Site, Boston

C1012AAR

Crinetics Study Site, CABA

C1405BCH

Crinetics Study Site, Buenos Aires

C1199ABB

Crinetics Study Site, CABA

X5000

Crinetics Study Site, Córdoba

60430-275

Crinetics Study Site, Fortaleza

80030-110

Crinetics Study Site, Curitiba

18618-686

Crinetics Study Site, Botucatu

13060-904

Crinetics Study Site, Campinas

20231-092

Crinetics Study Site, Rio de Janeiro

05403-000

Crinetics Study Site, São Paulo

050000

Crinetics Study Site, Shijiazhuang

00168

Crinetics Study Site, Roma

85-605

Crinetics Study Site, Bydgoszcz

60-355

Crinetics Study Site, Poznan

50-367

Crinetics Study Site, Wroclaw

08035

Crinetics Study Site, Barcelona

EC1M 6BQ

Crinetics Study Site, London

Sponsors
All Listed Sponsors
lead

Crinetics Pharmaceuticals Inc.

INDUSTRY